Functional Testing Underlying Coronary Revascularisation (FUTURE)
Multivessel Coronary Artery Disease, Vessel Disease, Stable Angina
About this trial
This is an interventional diagnostic trial for Multivessel Coronary Artery Disease focused on measuring fractional flow reserve, multivessel coronary artery disease, angiography
Eligibility Criteria
Inclusion Criteria:
- age > 18
referred to the cardiologist for one of the following medical condition :
- ST segment elevation myocardial infarction evolving for more than 7 days after revascularization of culprit coronary artery or
- no ST elevation acute coronary syndrome with or without troponin (T or I) elevation and medically stabilized for at least 12 hours or
- stable angina (CCS I, II or III) or
- chest pain diagnosis with suspicion of CAD or with ischemia certificated by non invasive tests.
- patients with at least 2 vessel disease (≥50% stenosis on angiography) including the left anterior descending coronary artery or with single vessel disease on left main coronary artery
- Patient willing and able to provide informed, written consent
- Patient not under legal protection
- Patient benefiting from the French Health Insurance
Exclusion Criteria:
- Pregnancy, childbearing, absence of effective contraception
- Previous coronary bypass surgery
- Planned associated valvular surgery
- Life expectancy < 2 years
Sites / Locations
- HOSPICES
Arms of the Study
Arm 1
Arm 2
Other
Other
FRACTIONAL FLOW RESERVE
ANGIOGRAPHY
Patients will have FFR measured in each diseased vessel identified by the coronary angiographic evaluation. Intra-coronary adenosine (at least 100 micrograms performed 2 times) OR intravenous adenosine (at a dose of 140µg/kg/min during at least 4 minutes) will be administered prior to FFR assessment. Revascularization strategy will be based upon FFR findings and revascularization either by coronary stenting or CABG will only be performed on target lesions with FFR≤0.8.
Patients undergo an angiography. Based on angiographic evaluation, the physicians define the revascularization strategy.